BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 143508)

  • 1. Biochemical aspects of Huntington's chorea.
    Caraceni T; Calderini G; Consolazione A; Riva E; Algeri S; Girotti F; Spreafico R; Branciforti A; Dall'olio A; Morselli PL
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):581-7. PubMed ID: 143508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemistry of dopamine in Huntington's dementia and normal aging.
    Stahl SM; Thiemann S; Faull KF; Barchas JD; Berger PA
    Arch Gen Psychiatry; 1986 Feb; 43(2):161-4. PubMed ID: 2936315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea.
    Mattsson B; Persson SA
    Acta Psychiatr Scand Suppl; 1974; 255():245-59. PubMed ID: 4282556
    [No Abstract]   [Full Text] [Related]  

  • 4. Homovanilic acid in Huntington's disease and Sydenham's chorea.
    Cunha L; Oliveira CR; Diniz M; Amaral R; Conçalves AF; Pio-Abreu J
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):258-61. PubMed ID: 6453208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (HIAA) in the CSF after administration of probenecid in Huntington's chorea. Effect of lithium carbonate].
    Livrea P; Di Reda L; Ragno G; Germinario L; Papagno G
    Riv Neurobiol; 1977; 23(3):149-59. PubMed ID: 154166
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative analysis of indices of central dopaminergic functions in man.
    Bagdy G; Arató M; Baraczka K; Fekete MI
    Life Sci; 1983 Jun; 32(23):2667-76. PubMed ID: 6855463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amine metabolites in the cerbrospinal fluid in Huntington's chorea.
    Curzon G; Gumpert J; Sharpe D
    J Neurol Neurosurg Psychiatry; 1972 Aug; 35(4):514-9. PubMed ID: 4261957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease.
    García Ruiz PJ; Mena MA; Sanchez Bernardos V; Díaz Neira W; Gimenez Roldan S; Benitez J; García de Yebenes J
    Clin Neuropharmacol; 1995 Feb; 18(1):58-63. PubMed ID: 8665535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
    Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
    Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with disulfiram in huntington's chorea.
    Mattsson B; Bertilsson L
    Acta Psychiatr Scand Suppl; 1974; 255():261-8. PubMed ID: 4282557
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF homovanillic acid: an index of dopaminergic activity.
    Curzon G
    Adv Neurol; 1975; 9():349-57. PubMed ID: 125031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebrospinal fluid metabolism of biogenic amines in Huntington chorea].
    Loeb C; Roccatagliata G; Albano C; Lamedica G; Abbruzzese G; Canini S
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 119(2):333-42. PubMed ID: 137520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.
    Agren H; Mefford IN; Rudorfer MV; Linnoila M; Potter WZ
    J Psychiatr Res; 1986; 20(3):175-93. PubMed ID: 2430098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical parameters during neuroleptic treatment. II. Antipsychotic effect of haloperidol in patients with chronic organic brain damage.
    Schilkrut R; Rüther E; Ackenheil M; Eben E; Hippius H
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):37-42. PubMed ID: 981321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homovanillic acid and 5-hydroxyindole-acetic acid in the csf of patients after a severe head injury. I. Lumbar csf concentration in chronic brain post-traumatic syndromes.
    Bareggi SR; Porta M; Selenati A; Assael BM; Calderini G; Collice M; Rossanda M; Morselli PL
    Eur Neurol; 1975; 13(6):528-44. PubMed ID: 1193100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet dopamine uptake in Huntington's chorea and Gilles de la Tourette's syndrome: effect of haloperidol.
    Butterworth RF; Gonce M; Barbeau A
    Can J Neurol Sci; 1977 Nov; 4(4):285-8. PubMed ID: 145893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Huntington's chorea. Effect of serotonin depletion.
    Chase TN; Watanabe AM; Brodie KH; Donnelly EF
    Arch Neurol; 1972 Mar; 26(3):282-4. PubMed ID: 4258630
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentration of 5-hydroxyindoleacetic acid, homovanillic acid, and tryptophan in the cerebrospinal fluid of depressed patients before and after ECT.
    Abrams R; Essman WB; Taylor MA; Fink M
    Biol Psychiatry; 1976 Feb; 11(1):85-90. PubMed ID: 1260078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.